Monthly Archives: March 2010
Pharma Cheers Health Reform Legislation
Image by SEIU International via Flickr
After months of increasingly rancorous debate, the House finally approved legislation March 21 that makes significant changes in the nation’s health care system. The Senate is slated to approve the House-passed changes to its original reform bill shortly.
Of most importance to pharmaceutical companies, the legislation promises to significantly expand the [...]
Posted in News Tagged Health care, health insurance, Insurance, Medicaid, Medicare, Medicare Part D coverage gap, Prescription drug, United States 3 Comments
Parallel Importers Framed in Europe
Guest blog by Pharmaceutical Executive Europe’s Brussels correspondent, Reflector.
The European debate about combating counterfeit medicines is generating a lot of heat in Brussels as it comes to a head. This month the European Parliament is starting to tackle the detail of the European Commission’s proposal to stop falsified products getting into the legal supply [...]
Posted in Strategy Leave a comment
Tauzin’s Farewell to PhRMA
Image via Wikipedia
In an emotional farewell address to PhRMA, President Billy Tauzin recapped his five years at the helm of the organization and his efforts to “recapture the value of the PhRMA brand” and to “re-earn the trust of people who had lost faith in us.” “We had to take the target off our backs—to [...]
A Critical Path to New TB Treatments
Image via Wikipedia
FDA Commissioner Margaret Hamburg announced, on Thursday, a new joint initiative between industry, FDA, and non-profit organizations designed to fast-track modern combination treatments for tuberculosis. Where once it took more than two decades to create new therapies for TB, this collaboration is expected to produce working treatments in less than six years, providing [...]

Judge Spikes Myriad Genetic’s Control of Genes